Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Conflicts with teachers are risk factor for school shootings

  • New study throws into question long-held belief about depression

  • Alcohol-dependence gene linked to neurotransmitter

  • Xenon exposure shown to erase traumatic memories

  • Social class makes a difference in how children tackle classroom problems

  • Inside the Teenage Brain: New Studies Explain Risky Behavior

  • Three-quarters of depressed cancer patients do not receive treatment for depression; new approach could transform care

  • Baicalin suppresses iron accumulation after substantia nigra injury

  • Factors predicting functional recovery of upper limb after peripheral nerve injuries

  • Collaborative care intervention improves depression among teens

  •